Detalles de la búsqueda
1.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32877583
2.
Capmatinib in Japanese patients with MET exon 14 skipping-mutated or MET-amplified advanced NSCLC: GEOMETRY mono-1 study.
Cancer Sci
; 112(4): 1556-1566, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33506571
3.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 112(12): 5000-5010, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543477
4.
Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis.
BMC Cancer
; 21(1): 924, 2021 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34399710
5.
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib.
BMC Cancer
; 21(1): 57, 2021 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33435905
6.
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
Jpn J Clin Oncol
; 51(1): 106-113, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33020837
7.
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer.
Cancer Sci
; 111(12): 4442-4452, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770608
8.
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study.
Cancer Sci
; 111(10): 3726-3738, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681682
9.
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data.
Cancer Sci
; 111(10): 3705-3713, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639668
10.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 111(12): 4480-4489, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926507
11.
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
Cancer
; 126(2): 373-380, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769875
12.
Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.
BMC Cancer
; 20(1): 103, 2020 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32028909
13.
Therapies after first-line afatinib in patients with EGFRm+ NSCLC in Japan: retrospective analysis of LUX-Lung 3.
Future Oncol
; 16(4): 49-60, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922425
14.
Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.
Pathol Int
; 70(5): 253-261, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970865
15.
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement.
Int J Mol Sci
; 21(7)2020 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32283823
16.
Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysis.
Cancer Sci
; 110(9): 2884-2893, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31265163
17.
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
Cancer
; 125(6): 892-901, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30512189
18.
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
Invest New Drugs
; 37(6): 1207-1217, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790152
19.
Anaplastic lymphoma kinase expression in small-cell lung cancer.
Histopathology
; 75(1): 20-28, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790327
20.
Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.
Jpn J Clin Oncol
; 49(7): 614-619, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30916304